<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30247950</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>15</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1557-7708</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>24</Volume>                    <Issue>9-10</Issue>                    <PubDate>                        <MedlineDate>2018 Sep/Oct</MedlineDate>                    </PubDate>                </JournalIssue>                <Title>Journal of alternative and complementary medicine (New York, N.Y.)</Title>                <ISOAbbreviation>J Altern Complement Med</ISOAbbreviation>            </Journal>            <ArticleTitle>Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.</ArticleTitle>            <Pagination>                <MedlinePgn>954-961</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1089/acm.2018.0159</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Evaluate the safety and clinical response of complementary treatment with European mistletoe extracts during chemotherapy.</AbstractText>                <AbstractText Label="DESIGN" NlmCategory="METHODS">Monocentric controlled trial with 95 patients randomized into three groups.</AbstractText>                <AbstractText Label="SETTINGS/LOCATION" NlmCategory="METHODS">National Cancer Research Center of Serbia.</AbstractText>                <AbstractText Label="SUBJECTS" NlmCategory="METHODS">Breast cancer patients (stage T<sub>1-3</sub>N<sub>0-2</sub>M<sub>0</sub>) undergoing surgery and adjuvant chemotherapy with six cycles of cyclophosphamide, adriamycin, and 5-fluorouracil.</AbstractText>                <AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Two different European mistletoe extracts (Helixor A, Iscador M Spez) were injected three times per week during 18 weeks of chemotherapy in the mistletoe group. Five-year follow-up of routine visits was documented in case report forms.</AbstractText>                <AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">Safety was assessed by measuring adverse events, body temperature during chemotherapy, and probability of relapse or metastasis in a 5-year follow-up. During chemotherapy, the neutrophil count and quality of life according to EORTC QLQ-C30 were assessed.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The two patient groups receiving different complementary mistletoe treatments were integrated into one mistletoe group for this safety analysis. Patients in the mistletoe group did not develop more fever symptoms than patients in the control group (two short-term events in each group). No significant differences in probability of relapse or metastasis were measured between the groups (p = 0.7637). The mistletoe group showed a trend toward less neutropenia (p = 0.178) and improved pain and appetite loss scores (p &lt; 0.0001 and p = 0.047, respectively) while having positive, but not significant, impact on other EORTC QLQ-C30 scores.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Mistletoe extracts were safe in this clinical study. Neither did subcutaneous injections induce fever, nor did they influence the frequency of relapse and metastasis within 5 years. This result suggests that mistletoe extracts had no adverse interactions with the anticancer agents used in this study. Furthermore, certain side effects of chemotherapy decreased under this complementary treatment in breast cancer patients.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Pelzer</LastName>                    <ForeName>Florian</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>1 Society for Cancer Research, Hiscia Institute , Arlesheim, Switzerland .</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tröger</LastName>                    <ForeName>Wilfried</ForeName>                    <Initials>W</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Nat</LastName>                    <ForeName>Dr Rer</ForeName>                    <Initials>DR</Initials>                    <AffiliationInfo>                        <Affiliation>2 Clinical Research Dr. Tröger (CRDT) , Freiburg, Germany .</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Altern Complement Med</MedlineTA>            <NlmUniqueID>9508124</NlmUniqueID>            <ISSNLinking>1075-5535</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2004 Mar-Apr;24(2C):1293-302</RefSource>                <PMID Version="1">15154663</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Integr Cancer Ther. 2010 Jun;9(2):142-57</RefSource>                <PMID Version="1">20483874</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Evid Based Complement Alternat Med. 2014;2014:430518</RefSource>                <PMID Version="1">24701238</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Onkologie. 2002 Aug;25(4):374-80</RefSource>                <PMID Version="1">12232491</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Clin Cancer Res. 2009 Jun 11;28:79</RefSource>                <PMID Version="1">19519890</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arzneimittelforschung. 2006 Jun;56(6A):508-15</RefSource>                <PMID Version="1">16927532</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Ther. 1998 May;5(3):181-7</RefSource>                <PMID Version="1">10099057</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 1993 Mar 3;85(5):365-76</RefSource>                <PMID Version="1">8433390</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer (Auckl). 2012;6:173-80</RefSource>                <PMID Version="1">23150723</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2004 Jan-Feb;24(1):303-9</RefSource>                <PMID Version="1">15015612</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2001 Jan;37(1):23-31</RefSource>                <PMID Version="1">11165126</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2016 Feb 15;122(4):598-610</RefSource>                <PMID Version="1">26599199</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2013 Dec;49(18):3788-97</RefSource>                <PMID Version="1">23890767</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2006 Mar-Apr;26(2B):1519-29</RefSource>                <PMID Version="1">16619567</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2013 Mar;49(5):1058-64</RefSource>                <PMID Version="1">23218588</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Complement Altern Med. 2014 Jan 08;14:6</RefSource>                <PMID Version="1">24397864</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Evid Based Complement Alternat Med. 2014;2014:724258</RefSource>                <PMID Version="1">24672577</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Complement Altern Med. 2016 Aug 04;16:271</RefSource>                <PMID Version="1">27491866</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Evid Based Complement Alternat Med. 2014;2014:210198</RefSource>                <PMID Version="1">24803944</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer (Auckl). 2009 Jul 06;3:35-45</RefSource>                <PMID Version="1">21556248</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000970" MajorTopicYN="Y">Antineoplastic Agents</DescriptorName>                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001831" MajorTopicYN="N">Body Temperature</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009503" MajorTopicYN="N">Neutropenia</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008517" MajorTopicYN="Y">Phytotherapy</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010936" MajorTopicYN="Y">Plant Extracts</DescriptorName>                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D028182" MajorTopicYN="Y">Viscum album</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">5-year follow-up</Keyword>            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">chemotherapy</Keyword>            <Keyword MajorTopicYN="N">mistletoe therapy</Keyword>            <Keyword MajorTopicYN="N">randomized clinical trial</Keyword>            <Keyword MajorTopicYN="N">safety</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30247950</ArticleId>            <ArticleId IdType="doi">10.1089/acm.2018.0159</ArticleId>            <ArticleId IdType="pmc">PMC6157372</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>